# Contrast-Enhanced Digital Mammography CEDM Market

> Contrast-Enhanced Digital Mammography (CEDM) Market Research Report By Technology (Screen-Film Contrast-Enhanced Digital Mammography, Digital Contrast Enhanced Mammography, Tomosynthesis Contrast-Enhanced Digital Mammography), By Application (Diagnostic Mammography, Screening Mammography, Preoperative Assessment, Postoperative Assessment), By End User (Hospitals, Imaging Centers, Breast Clinics, Research Institutions), By Modality (2D, 3D) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Industry Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.98%
- **2024:** $ 7.8 Billion
- **2025:** $ 8.34 Billion
- **2035:** $ 16.39 Billion
- **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Hologic (US), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Medical Systems (JP), Carestream Health (US), Konica Minolta (JP)

**Report ID:** MRFR/HC/28537-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** May 14, 2026

**URL:** https://www.marketresearchfuture.com/reports/contrast-enhanced-digital-mammography-cedm-market-30282

---

## Market Summary

## **Contrast Enhanced Digital Mammography (CEDM) Market Overview:**

As per MRFR analysis, the Contrast Enhanced Digital Mammography Market Size was estimated at 7.80 (USD Billion) in 2024. The Contrast Enhanced Digital Mammography Market Industry is expected to grow from 8.34 (USD Billion) in 2025 to 15.32 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.98% during the forecast period (2025 - 2034).

### **Key Contrast-Enhanced Digital Mammography (CEDM) Market Trends Highlighted**

The global Contrast-Enhanced Digital Mammography (CEDM) market is experiencing significant growth due to its ability to detect breast cancer at an earlier stage, leading to improved patient outcomes and reduced mortality rates.

The increasing prevalence of breast cancer and technological advancements in CEDM systems are major drivers of market expansion.

Opportunities for growth in the CEDM market lie in the development of new technologies that enhance image quality, reduce radiation exposure, and offer more cost-effective solutions. The integration of artificial intelligence (AI) and machine learning algorithms in CEDM systems holds promise for improved diagnostic accuracy and efficiency.

Recent trends indicate a shift toward 3D CEDM, which provides more detailed and accurate images. Additionally, the adoption of mobile CEDM units is expanding access to breast cancer screening in underserved areas.

The growing demand for personalized medicine is also creating opportunities for the development of customized CEDM systems tailored to individual patient needs.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Contrast Enhanced Digital Mammography (CEDM) Market Drivers**

### Rising Prevalence of Breast Cancer

The main factor driving the growth of the Global Contrast Enhanced Digital Mammography (CEDM) Market Industry is the increasing incidence of breast cancer. Breast cancer is the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2020.

CEDM is a specialized imaging technique that uses a contrast agent to improve the visibility of breast tissue, enabling the more accurate detection of tumors and other abnormalities.

As the incidence of breast cancer continues to rise, the demand for CEDM is also expected to increase to improve early detection and diagnosis rates.

### Technological Advancements in CEDM Systems

Technological advancements in CEDM systems is also one of the major driver for the Global Contrast Enhanced Digital Mammography (CEDM) Market Industry.

The technology has evolved over the years with the development of new contrast agents, image processing algorithms, and the integration of artificial intelligence. These advancements have resulted in improved image quality, low radiation exposure, and faster processing time which makes it a more efficient screening tool for cancer detection in breast.

### Increasing Awareness of CEDM

Also, heightened awareness of CEDM among healthcare professionals and patients has contributed to the growth of the Global Contrast Enhanced Digital Mammography (CEDM) Market Industry.

Education awareness and advocacy strategies, coupled with other numerous initiatives that are focusing on the benefits of diagnostic imaging with the use of mammography CEDM have promoted CEDM demand. As such, more women are likely to demand the diagnostic imaging in future.

## **Contrast Enhanced Digital Mammography (CEDM) Market Segment Insights:**

### **Contrast Enhanced Digital Mammography (CEDM) Market Technology Insights**

The Global Contrast Enhanced Digital Mammography (CEDM) Market is segmented by Technology into Screen-Film Contrast Enhanced Digital Mammography, Digital Contrast Enhanced Mammography, and Tomosynthesis Contrast Enhanced Digital Mammography.

Screen-Film Contrast Enhanced Digital Mammography Screen-film contrast enhanced digital mammography CEDM is a type of mammography that uses a special type of film to create images of the breast. The film is coated with a layer of phosphor, which emits light when it is exposed to X-rays. The light is then detected by a digital sensor, which converts it into an image.

CEDM is more sensitive than traditional mammography, which means that it can detect smaller tumors. It is also more accurate, which means that it can reduce the number of false positives. Digital Contrast Enhanced Mammography Digital contrast enhanced mammography DCEM is a type of mammography that uses a digital detector to create images of the breast.

The detector is made of a semiconductor material, which converts X-rays into electrical signals. The electrical signals are then processed by a computer, which creates an image. DCEM is more sensitive than traditional mammography, which means that it can detect smaller tumors.

It is also more accurate, which means that it can reduce the number of false positives. Tomosynthesis Contrast Enhanced Digital Mammography Tomosynthesis contrast enhanced digital mammography TCEDM is a type of mammography that uses a special type of X-ray machine to create 3D images of the breast.

The X-ray machine takes multiple images of the breast from different angles. The images are then processed by a computer, which creates a 3D image of the breast. TCEDM is more sensitive than traditional mammography, which means that it can detect smaller tumors.

The growth of the market is attributed to the increasing prevalence of breast cancer, the rising demand for more accurate and sensitive imaging techniques, and the growing adoption of advanced technologies such as TCEDM.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Contrast Enhanced Digital Mammography (CEDM) Market Application Insights**

The application segment of the Global Contrast Enhanced Digital Mammography (CEDM) Market is categorized into Diagnostic Mammography, Screening Mammography, Preoperative Assessment, and Postoperative Assessment.

Diagnostic Mammography accounted for the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing prevalence of breast cancer and the rising adoption of CEDM for early detection and diagnosis.

Screening Mammography is another significant application segment, driven by the growing awareness of breast cancer screening programs and government initiatives to promote early detection.

Preoperative Assessment and Postoperative Assessment are niche segments that are expected to witness steady growth due to the increasing use of CEDM for preoperative planning and postoperative monitoring.

Overall, the Global Contrast Enhanced Digital Mammography (CEDM) Market is poised for significant growth in the coming years, driven by the rising incidence of breast cancer, technological advancements, and increasing healthcare spending.

### **Contrast Enhanced Digital Mammography (CEDM) Market End User Insights**

The end-user segment of the Global Contrast Enhanced Digital Mammography (CEDM) Market comprises hospitals, imaging centers, breast clinics, and research institutions. Hospitals hold the largest market share due to the high volume of mammograms performed and the increasing adoption of CEDM technology.

Imaging centers are also witnessing significant growth, driven by the rising demand for specialized breast imaging services. Breast clinics, which focus exclusively on breast health, are expected to contribute to the market growth owing to the increasing awareness of breast cancer and the need for early detection. Research institutions play a crucial role in advancing CEDM technology and developing new applications.

### **Contrast Enhanced Digital Mammography (CEDM) Market Modality Insights**

The Modality segment of the Global Contrast Enhanced Digital Mammography (CEDM) Market is segmented into 2D and 3D. The 2D segment held a larger market share in 2023, accounting for approximately 60% of the global market revenue.

This dominance is attributed to the widespread availability and lower cost of 2D mammography systems compared to 3D systems. However, the 3D segment is projected to grow at a faster CAGR during the forecast period, owing to its superior ability to detect breast cancer at an early stage.

The increasing adoption of 3D mammography in screening programs and the growing awareness of its benefits are expected to drive the growth of this segment.

In 2024, the 3D segment is estimated to account for around 40% of the global Contrast Enhanced Digital Mammography (CEDM) Market revenue.

### **Contrast Enhanced Digital Mammography (CEDM) Market Regional Insights**

The Global Contrast Enhanced Digital Mammography (CEDM) Market segmentation by region offers insights into the market's regional dynamics. North America is anticipated to hold the largest market share owing to the high prevalence of breast cancer and the presence of advanced healthcare infrastructure.

Europe is projected to follow North America due to the rising awareness of breast cancer screening and the availability of reimbursement policies. The APAC region is expected to grow rapidly due to the increasing incidence of breast cancer and the growing adoption of advanced screening technologies.

South America and MEA are expected to have a steady growth rate due to the improving healthcare infrastructure and the increased awareness of breast cancer screening.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Contrast Enhanced Digital Mammography (CEDM) Market Key Players and Competitive Insights:**

Major players in the Contrast Enhanced Digital Mammography (CEDM) Market industry are continuously innovating and developing new products to meet the evolving needs of customers. Leading Contrast-Enhanced Digital Mammography (CEDM) Market players are focusing on expanding their global presence through strategic partnerships and collaborations.

The Contrast Enhanced Digital Mammography (CEDM) Market development is driven by the increasing adoption of advanced technologies and rising demand for improved healthcare services. The competitive landscape of the Contrast Enhanced Digital Mammography (CEDM) Market is characterized by the presence of both established and emerging players.

One of the leading companies in the Contrast Enhanced Digital Mammography (CEDM) Market is Hologic, Inc. The company offers a wide range of Contrast Enhanced Digital Mammography CEDM products, including 3D mammography systems and breast biopsy systems.

Hologic, Inc. has a strong global presence and is committed to providing innovative and cost-effective solutions to healthcare providers. The company's focus on research and development has enabled it to develop advanced technologies that enhance the accuracy and efficiency of breast cancer detection and diagnosis.

A prominent competitor in the Contrast Enhanced Digital Mammography (CEDM) Market is General Electric Company. The company offers a comprehensive portfolio of Contrast Enhanced Digital Mammography CEDM products, including mammography systems, breast imaging software, and biopsy devices.

General Electric Company has a strong brand recognition and a wide distribution network, which enables it to reach a large number of customers. The company's focus on customer satisfaction and commitment to quality have made it a trusted choice among healthcare providers.

### **Key Companies in the Contrast-Enhanced Digital Mammography (CEDM) Market Include:**

## **Contrast Enhanced Digital Mammography (CEDM) Market Industry Developments**

_The Contrast Enhanced Digital Mammography (CEDM) market is anticipated to grow significantly in the coming years, driven by factors such as the increasing prevalence of breast cancer, rising demand for early and accurate breast cancer detection, and technological advancements in CEDM systems._

_Major players in the CEDM market include Hologic, Inc., GE Healthcare, Siemens Healthineers, and Fujifilm Holdings Corporation. These companies are focusing on developing advanced CEDM systems with improved image quality, reduced radiation exposure, and enhanced diagnostic capabilities._

_Recent developments in the CEDM market include the launch of new products such as Hologic's Affirm Prone Biopsy System and GE Healthcare's Senographe Pristina with Pristina DUE. These systems offer improved patient comfort, faster imaging times, and more accurate results._

_Overall, the CEDM market is expected to witness continued growth in the future, driven by increasing awareness about breast cancer screening, technological advancements, and favorable reimbursement policies._

## **Contrast Enhanced Digital Mammography (CEDM) Market Segmentation Insights**

### **Contrast Enhanced Digital Mammography (CEDM) Market Technology Outlook**

### **Contrast Enhanced Digital Mammography (CEDM) Market Application Outlook**

### **Contrast Enhanced Digital Mammography (CEDM) Market End User Outlook**

### **Contrast Enhanced Digital Mammography (CEDM) Market Modality Outlook**

### **Contrast Enhanced Digital Mammography (CEDM) Market Regional Outlook**

## Market Drivers

### Growing Awareness and Education

Growing awareness and education regarding breast health are pivotal drivers for the Contrast Enhanced Digital [Mammography](https://www.marketresearchfuture.com/reports/mammography-market-2443) (CEDM) Market. As public health campaigns and educational initiatives proliferate, more women are becoming informed about the importance of regular screenings and the benefits of advanced imaging technologies like CEDM. This heightened awareness is likely to lead to increased demand for CEDM services, as women seek out facilities that offer the latest diagnostic options. Additionally, healthcare providers are increasingly emphasizing the importance of early detection, which aligns with the capabilities of CEDM to identify abnormalities at earlier stages. Market trends suggest that as awareness continues to grow, the utilization of CEDM will expand, contributing to overall market growth.

### Regulatory Support and Guidelines

Regulatory support and guidelines play a crucial role in shaping the Contrast Enhanced Digital Mammography (CEDM) Market. Various health organizations and regulatory bodies are advocating for the adoption of advanced imaging technologies to improve breast cancer detection rates. These guidelines often recommend the use of CEDM for women with dense breast tissue, where traditional mammography may fall short. As these recommendations gain traction, healthcare providers are likely to invest in CEDM systems to comply with evolving standards. Furthermore, government initiatives aimed at enhancing breast cancer screening programs may provide additional incentives for facilities to adopt CEDM technology. This regulatory backing is expected to bolster market growth and encourage widespread implementation of CEDM.

### Rising Incidence of Breast Cancer

The increasing incidence of breast cancer is a primary driver for the Contrast Enhanced Digital Mammography (CEDM) Market. According to recent statistics, breast cancer remains one of the most prevalent cancers among women, with millions diagnosed annually. This alarming trend necessitates advanced diagnostic tools, such as CEDM, which enhances the detection of tumors that may not be visible through traditional mammography. The demand for effective screening methods is likely to rise as awareness about breast cancer increases, prompting healthcare providers to adopt CEDM technology. Furthermore, the potential for early detection and improved patient outcomes positions CEDM as a critical component in the fight against breast cancer, thereby driving market growth.

### Technological Innovations in Imaging

Technological innovations in imaging techniques are significantly influencing the Contrast Enhanced Digital Mammography (CEDM) Market. Recent advancements in imaging technology have led to the development of more sophisticated CEDM systems that provide enhanced image quality and improved diagnostic accuracy. These innovations include the integration of high-resolution detectors and advanced contrast agents, which facilitate better visualization of breast tissue. As healthcare facilities seek to upgrade their imaging capabilities, the adoption of CEDM is expected to increase. Market data indicates that the introduction of these advanced systems could lead to a substantial rise in CEDM installations, further propelling the market forward. The continuous evolution of imaging technology suggests a promising future for CEDM in clinical settings.

### Increasing Investment in Healthcare Infrastructure

Increasing investment in healthcare infrastructure is a significant driver for the Contrast Enhanced Digital Mammography (CEDM) Market. As countries prioritize healthcare improvements, there is a notable trend towards upgrading diagnostic facilities and expanding access to advanced imaging technologies. This investment often includes the procurement of CEDM systems, which are recognized for their ability to enhance breast cancer detection. Market data indicates that regions with substantial healthcare funding are more likely to see a rise in CEDM adoption, as facilities seek to provide state-of-the-art diagnostic services. The ongoing commitment to improving healthcare infrastructure suggests a favorable environment for the growth of the CEDM market, as more facilities integrate these advanced technologies into their offerings.

## Future Outlook

The Contrast Enhanced Digital Mammography (CEDM) Market is projected to grow at a 6.98% CAGR from 2025 to 2035, driven by technological advancements and increasing breast cancer awareness.

**New opportunities:**

- Development of AI-driven diagnostic tools for enhanced imaging accuracy.
- Expansion of mobile CEDM units for rural healthcare accessibility.
- Partnerships with insurance providers to improve reimbursement models for CEDM services.

By 2035, the CEDM market is expected to achieve substantial growth, reflecting its critical role in breast cancer detection.

## Segment Insights

### By Technology: Digital Contrast Enhanced Mammography (Largest) vs. Screen-Film Contrast Enhanced Digital Mammography (Fastest-Growing)

In the Contrast Enhanced Digital Mammography (CEDM) market, the technology segment is predominantly led by Digital Contrast Enhanced Mammography, which holds the largest market share due to its advanced digital capabilities and superior imaging quality. Screen-Film Contrast Enhanced Digital Mammography, while traditionally significant, is now experiencing a decline in its market presence as healthcare providers shift towards more efficient and effective digital solutions. Tomosynthesis Contrast Enhanced Digital Mammography is also gaining traction but remains a smaller part of the overall market share, focusing on enhancing diagnostic accuracy through three-dimensional imaging. The growth trends in the CEDM technology segment are notably driven by advancements in imaging technologies and increasing awareness among healthcare practitioners about the benefits of digital systems. The rising incidence of breast cancer and the urgent need for early detection are further propelling the demand for sophisticated imaging techniques. Digital Contrast Enhanced Mammography's market dominance aligns with technological improvements, while Screen-Film CEDM's faster growth rate signifies a transitional phase in which legacy systems are rapidly evolving to meet modern standards, enhancing accessibility and efficiency in diagnostics.

Technology: Digital Contrast Enhanced Mammography (Dominant) vs. Screen-Film Contrast Enhanced Digital Mammography (Emerging)

Digital Contrast Enhanced Mammography stands as the dominant technology in the CEDM market, characterized by its high-resolution imaging and enhanced contrast capabilities, which significantly improve diagnostic accuracy. This technology offers numerous benefits such as reduced radiation exposure and enhanced visualization of breast tissues, making it a preferred choice among healthcare providers. Conversely, Screen-Film Contrast Enhanced Digital Mammography is termed as an emerging technology, albeit gradually declining due to the shift towards digital methods. While it has been a staple in mammography for years, its limitations in terms of speed and efficiency are leading to a decrease in its adoption. However, it is still being utilized in some practices, especially in settings with limited resources where transitioning to digital platforms is challenging.

### By Application: Screening Mammography (Largest) vs. Diagnostic Mammography (Fastest-Growing)

In the Contrast Enhanced Digital Mammography (CEDM) Market, the application segment is predominated by Screening Mammography, which holds the largest market share owing to its critical role in early breast cancer detection. Diagnostic Mammography follows as a significant segment, catering to women with abnormal findings in screening procedures. Preoperative and Postoperative Assessments also contribute to the market, though they represent smaller portions of the application landscape, reflecting their specialized use cases within clinical pathways.

Screening Mammography (Dominant) vs. Diagnostic Mammography (Emerging)

Screening Mammography stands out as the dominant application in the CEDM Market, primarily due to its essential function in routine breast health evaluations, enabling early diagnosis and treatment of breast cancer. Meanwhile, Diagnostic Mammography is emerging as a credible contender, particularly in settings where there is a heightened need for thorough investigations following an initial abnormal screening result. The growth in Diagnostic Mammography is fueled by advancements in imaging technology and increasing awareness among healthcare providers about the importance of tailored diagnostic approaches. This dynamic between dominant and emerging applications is pivotal in shaping the future landscape of breast imaging.

### By End User: Hospitals (Largest) vs. Imaging Centers (Fastest-Growing)

In the Contrast Enhanced Digital Mammography (CEDM) market, hospitals hold the largest market share as they are the primary users of advanced imaging technologies. Their extensive resources and patient volume enable them to invest significantly in CEDM systems, driving a substantial portion of market revenues. Imaging centers, while smaller in overall share, have been gaining ground rapidly as they offer accessible, affordable, and specialized services to patients seeking breast imaging options. These centers often collaborate with hospitals to expand their service offerings, strengthening their position in the market. The growth trends in the CEDM market for end users are primarily driven by an increasing emphasis on early breast cancer detection and the technological advancements in imaging. Hospitals are adopting CEDM systems to enhance diagnostics capabilities, while imaging centers are incorporating these technologies to attract patients seeking more personalized care. Research institutions and breast clinics also contribute significantly to the growth, focusing on innovation and specialized screening programs, which indicates a robust future for all end user segments.

Hospitals (Dominant) vs. Imaging Centers (Emerging)

Hospitals are positioned as the dominant player in the CEDM market due to their ability to leverage advanced technologies and integrate them into comprehensive patient care frameworks. These institutions typically have the necessary funding and infrastructure to support ongoing developments and the implementation of state-of-the-art imaging modalities. In contrast, imaging centers are emerging as key competitors by offering niche services that focus on convenience and patient-centric care. With shorter wait times and lower costs, imaging centers appeal to a growing demographic of patients seeking efficient outpatient services. This dynamic is fostering collaboration between hospitals and imaging centers, aiming to enhance overall service delivery while addressing the increasing demand for advanced breast imaging technologies.

### By Modality: 3D (Largest) vs. 2D (Fastest-Growing)

In the Contrast Enhanced Digital Mammography (CEDM) Market, the 3D modality currently holds the largest market share due to its superior imaging capabilities, which enable more precise detection of breast abnormalities. The enhanced visualization provided by 3D mammography allows for improved diagnostic accuracy and has become the preferred choice among healthcare professionals, thus securing its dominant position in the market. Conversely, the 2D modality, while trailing behind in overall market share, is rapidly gaining traction as advancements in imaging technology and increased awareness of its benefits contribute to its growth in usage.

Modality: 3D (Dominant) vs. 2D (Emerging)

The 3D modality in the Contrast Enhanced Digital Mammography (CEDM) Market is characterized by its ability to provide three-dimensional images of the breast, facilitating more detailed examinations compared to its 2D counterpart. This technology dramatically reduces false positives and enhances the accuracy of cancer detection, making it the dominant choice among radiologists. In contrast, the 2D modality is emerging as a viable option, particularly for facilities with budget constraints or those in areas with limited access to advanced imaging technologies. Although it lacks the depth of information offered by 3D imaging, improvements in 2D technique continue to drive its adoption, making it an important segment within the market.

## Regional Market Share Analysis

### North America : Leading Innovation and Adoption

North America is the largest market for Contrast Enhanced Digital Mammography (CEDM), holding approximately 45% of the global market share. The region's growth is driven by increasing breast cancer awareness, advancements in imaging technology, and supportive healthcare policies. Regulatory bodies like the FDA have been pivotal in approving innovative CEDM systems, enhancing patient access to advanced diagnostic tools. The United States is the primary contributor to this market, with significant investments from key players such as GE Healthcare and Hologic. The competitive landscape is characterized by rapid technological advancements and collaborations among leading firms. Canada also plays a vital role, focusing on improving healthcare infrastructure and access to CEDM, further solidifying North America's position in the global market.

### Europe : Regulatory Support and Growth

Europe is the second-largest market for Contrast Enhanced Digital Mammography (CEDM), accounting for approximately 30% of the global market share. The region benefits from stringent regulations and guidelines that promote the adoption of advanced imaging technologies. Countries like Germany and the UK are leading the charge, driven by increasing healthcare expenditure and a growing emphasis on early cancer detection. Germany stands out as a key player, with significant contributions from Siemens Healthineers and Philips Healthcare. The competitive landscape is marked by a focus on innovation and partnerships among leading firms. The European market is also witnessing a rise in awareness campaigns aimed at educating the public about the benefits of CEDM, further driving demand.

### Asia-Pacific : Rapid Growth and Adoption

Asia-Pacific is witnessing rapid growth in the Contrast Enhanced Digital Mammography (CEDM) market, holding about 15% of the global share. The region's expansion is fueled by increasing healthcare investments, rising awareness of breast cancer, and the adoption of advanced medical technologies. Countries like Japan and China are at the forefront, with supportive government initiatives aimed at enhancing diagnostic capabilities. Japan, with its strong healthcare infrastructure, is home to key players like Canon Medical Systems and Fujifilm Medical Systems. The competitive landscape is evolving, with local manufacturers emerging alongside established global firms. The region's focus on improving healthcare access and quality is expected to drive further growth in the CEDM market.

### Middle East and Africa : Untapped Potential and Challenges

The Middle East and Africa (MEA) region represents an emerging market for Contrast Enhanced Digital Mammography (CEDM), holding around 10% of the global market share. The growth is driven by increasing healthcare investments, rising awareness of breast cancer, and the need for advanced diagnostic tools. Countries like South Africa and the UAE are leading the way, focusing on improving healthcare infrastructure and access to innovative technologies. South Africa is a key player in the MEA market, with efforts to enhance early detection programs and increase access to CEDM. The competitive landscape is characterized by a mix of local and international players, with a growing emphasis on partnerships to improve healthcare delivery. The region's potential for growth is significant, but challenges such as regulatory hurdles and economic disparities remain.

## Competitive Benchmarking

Major players in the Contrast Enhanced Digital Mammography (CEDM) Market industry are continuously innovating and developing new products to meet the evolving needs of customers. Leading Contrast-Enhanced Digital Mammography (CEDM) Market players are focusing on expanding their global presence through strategic partnerships and collaborations.
The Contrast Enhanced Digital Mammography (CEDM) Market development is driven by the increasing adoption of advanced technologies and rising demand for improved healthcare services. The competitive landscape of the Contrast Enhanced Digital Mammography (CEDM) Market is characterized by the presence of both established and emerging players.
One of the leading companies in the Contrast Enhanced Digital Mammography (CEDM) Market is Hologic, Inc. The company offers a wide range of Contrast Enhanced Digital Mammography CEDM products, including 3D mammography systems and [breast biopsy](https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288) systems.
Hologic, Inc. has a strong global presence and is committed to providing innovative and cost-effective solutions to healthcare providers. The company's focus on research and development has enabled it to develop advanced technologies that enhance the accuracy and efficiency of breast cancer detection and diagnosis.
A prominent competitor in the Contrast Enhanced Digital Mammography (CEDM) Market is General Electric Company. The company offers a comprehensive portfolio of Contrast Enhanced Digital Mammography CEDM products, including mammography systems, breast imaging software, and biopsy devices.
General Electric Company has a strong brand recognition and a wide distribution network, which enables it to reach a large number of customers. The company's focus on customer satisfaction and commitment to quality have made it a trusted choice among healthcare providers.

## Recent News & Developments

_The Contrast Enhanced Digital Mammography (CEDM) market is anticipated to grow significantly in the coming years, driven by factors such as the increasing prevalence of breast cancer, rising demand for early and accurate breast cancer detection, and technological advancements in CEDM systems._

_Major players in the CEDM market include Hologic, Inc., GE Healthcare, Siemens Healthineers, and Fujifilm Holdings Corporation. These companies are focusing on developing advanced CEDM systems with improved image quality, reduced radiation exposure, and enhanced diagnostic capabilities._

_Recent developments in the CEDM market include the launch of new products such as Hologic's Affirm Prone Biopsy System and GE Healthcare's Senographe Pristina with Pristina DUE. These systems offer improved patient comfort, faster imaging times, and more accurate results._

_Overall, the CEDM market is expected to witness continued growth in the future, driven by increasing awareness about breast cancer screening, technological advancements, and favorable reimbursement policies._

## Report Scope

| MARKET SIZE 2024 | 7.8(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 8.344(USD Billion) |
| MARKET SIZE 2035 | 16.39(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.98% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Hologic (US), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Medical Systems (JP), Carestream Health (US), Konica Minolta (JP) |
| Segments Covered | Technology, Application, End User, Modality, Regional |
| Key Market Opportunities | Advancements in imaging technology enhance early breast cancer detection in the Contrast Enhanced Digital Mammography (CEDM) Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive the adoption of Contrast Enhanced Digital Mammography in diagnostic imaging. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Contrast Enhanced Digital Mammography (CEDM) Market by 2035?**
A: The projected market valuation for the CEDM Market by 2035 is 16.39 USD Billion.

**Q: What was the overall market valuation of the CEDM Market in 2024?**
A: The overall market valuation of the CEDM Market in 2024 was 7.8 USD Billion.

**Q: What is the expected CAGR for the CEDM Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the CEDM Market during the forecast period 2025 - 2035 is 6.98%.

**Q: Which companies are considered key players in the CEDM Market?**
A: Key players in the CEDM Market include GE Healthcare, Siemens Healthineers, Hologic, Philips Healthcare, Canon Medical Systems, Fujifilm Medical Systems, Carestream Health, and Konica Minolta.

**Q: What are the main technology segments within the CEDM Market?**
A: The main technology segments within the CEDM Market include Screen-Film Contrast Enhanced Digital Mammography, Digital Contrast Enhanced Mammography, and Tomosynthesis Contrast Enhanced Digital Mammography.

**Q: How did the Digital Contrast Enhanced Mammography segment perform in 2024?**
A: In 2024, the Digital Contrast Enhanced Mammography segment was valued at 3.12 USD Billion.

**Q: What is the projected valuation for the Screening Mammography application by 2035?**
A: The projected valuation for the Screening Mammography application by 2035 is 5.0 USD Billion.

**Q: Which end-user segment is expected to have the highest valuation by 2035?**
A: By 2035, the Hospitals end-user segment is expected to have the highest valuation at 6.67 USD Billion.

**Q: What is the expected growth for the 3D modality segment in the CEDM Market?**
A: The 3D modality segment is projected to grow to 9.66 USD Billion by 2035.

**Q: How does the performance of the Preoperative Assessment application compare to the Postoperative Assessment application by 2035?**
A: By 2035, the Preoperative Assessment application is projected to reach 3.5 USD Billion, while the Postoperative Assessment application is expected to reach 3.89 USD Billion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/contrast-enhanced-digital-mammography-cedm-market-30282*
